Clinical trial

Dolutegravir in Reservoirs

NCT02924389

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2016-09-01

PhasePHASE4

Study timeline

Study start (actual)2016-09-01Date precision: month

Registry last updated2022-12-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIVunresolved

Interventions

dolutegravirDRUG

TriumeqDRUG

TruvadaDRUG

Sponsors & collaborators

Emory Universitylead sponsor

National Institute of Allergy and Infectious Diseases (NIAID)collaborator

Mapped research locations

AtlantaGeorgia, United States3

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02924389 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.